Podocyte-Targeted Therapy Shows Efficacy for Patients With FSGS

About half of patients who present with proteinuria from focal segmental glomerulosclerosis (FSGS) progress to kidney failure within 5 to 10 years. Research links this decline to overactivity of the transient receptor potential cation channel,…